•  
  •  
  •  
  •  

2026-03-27 08:40:14

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • EaseMyTrip Enters Exclusive Partnership with MSTC Ltd. to Power Travel Services for Govt Sector
  • Sundaram-Clayton Completes Rs 558.62 Cr Land Sale
  • 3i Infotech Digital BPS Ltd receives order from Mahanagar Gas Ltd
  • AZAD Engineering Ltd signs long term contract with Mitsubishi Heavy Industries Ltd
  • PNGS Gargi Fashion Jewellery Ltd opens new store in Pune

Keywords Selected:  SCI

Research

  • Bayer Cropscience - Q1FY23 Result Update - Good set of numbers in challenging scenario - Accumulate
  • Bayer Cropscience - Q4FY22 Result Update - Healthy all round performance - BUY
  • Krishna Institute of Medical Sciences - Management Meet Update - Stepping up - BUY
  • Solara Active Pharma Sciences - Recovering business provides respite - ICICI Securities
  • IPO Review - Supriya Lifescience Ltd - ICICI Direct
  • Supriya Lifescience - IPO - Strong R&D Focused API Player - Reliance Research

IPO News

  • Kronox Lab Sciences IPO subscribed 117.25 times on Final Day
  • Kronox Lab Sciences IPO fully subscribed in less than half an hour of opening
  • Kronox Lab Sciences Limited raises Rs. 39.04 crore from Anchor Investors
  • Kronox Lab Sciences Ltd's Initial Public Offering to open on Friday June 3, 2024
  • Kronox Lab Sciences gets SEBI nod to float IPO
  • Kronox Lab Sciences Limited files DRHP for IPO
  • Rockingdeals IPO opens today, Anchor Book fully subscribed
  • Rockingdeals IPO price band announced at Rs. 136-Rs. 140 per share, issue opens on November 22
  • Rockingdeals Circular Economy Ltd files DRHP with NSE Emerge for IPO
  • Shilpa Pharma Lifesciences Ltd to file for IPO

Stock Report

  • Zydus launches Semaglutide Injection in an innovative, reusable multi-dose pen device in India
  • Eris Lifesciences Ltd to launch Weekly Shot of Semaglutide Starting at ₹220 Per Shot
  • Zydus launches Aerolife Mini™, to simplify inhaler use for asthma and COPD patients
  • Mazagon Dock Shipbuilders Ltd enters into contract with Shipping Corporation of India Ltd
  • Zydus and Torrent Pharma sign licensing agreement to co-market innovative Semaglutide Injection in India
  • Strides Strengthens its Africa Business with the Acquisition of Multiple Generic Brands from Sandoz
  • Lupin and Zydus Sign Licensing Agreement for Co-marketing Innovative Semaglutide Injection in India
  • Zydus' new drug discovery, 'Desidustat' licensed to China Medical System Holdings receives approval from NMPA of China
  • Zydus receives final approval from USFDA for Cevimeline Hydrochloride Capsules 30mg
  • Zydus expands companion diagnostics portfolio with the launch of AI-powered Continuous Glucose Monitor Diasens™ and GlucoLive™
  • Avio Smart Market Stack Invests Rs 7.5 Cr in Huwel Lifesciences
  • Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg
  • Zydus Lifesciences announces successful clinical development of Pembrolizumab biosimilar FYB206, marking a milestone toward USFDA filing
  • Indogulf Cropsciences Signs MoA for PM's Fellowship with ICAR-IARI
  • Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry
  • Eris Lifesciences Ltd announces Strategic Partnership with Natco Pharma Ltd for Semaglutide Launch in India
  • Closure of USFDA inspection at Zydus' Injectable plant at Ahmedabad
  • Zydus launches biosimilar Aflibercept 2 mg ANYRA™ for advancing ophthalmic care
  • Zydus receives final approval from USFDA for Bosentan tablets for oral suspension, 32 mg
  • Zydus launches PEPAIR™, a first in India, affordable, drug-free, handheld device for better respiratory health
  • USFDA inspection at the manufacturing facility of Enzene Biosciences Limited
  • Fire at Alivus Life Sciences Limited's API plant
  • Eris delivers 10% YoY growth in DBF business and 11% in consolidated revenue during Q3 FY26
  • Supriya Lifescience Delivers Strong Q3 FY26 Results with 11% YoY Revenue Growth

Industry News

  • Conscious Chemist announces INR 12 Cr funding from Atomic Capital, welcomes Apoorv Gautam to the Board

Mutual Funds

  • DSP Mutual Fund Repositions ELSS as a Discipline Tool, Not a Tax Product
  • DSP Mutual Fund expands passive range with MSCI India ETF for diversified India exposure

Latest Post

  • EaseMyTrip Enters Exclusive Partnership with MSTC Ltd. to Power Travel Services for Govt Sector
  • Sundaram-Clayton Completes Rs 558.62 Cr Land Sale
  • 3i Infotech Digital BPS Ltd receives order from Mahanagar Gas Ltd
  • AZAD Engineering Ltd signs long term contract with Mitsubishi Heavy Industries Ltd
  • PNGS Gargi Fashion Jewellery Ltd opens new store in Pune


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025